Dehydroepiandrosterone therapy for ameleoration of prostate hype

Details Dehydroepiandrosterone therapy for ameleoration of prostate hype Dehydroepiandrosterone therapy for ameleoration of prostate hype

1987-05-06

1989-05-30

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

A61K 3156

Patent

active

048351474

ABSTRACT:
Dehydroepiandrosterone and acceptable salts thereof are utilized for sexual disfunction therapy.

REFERENCES:
patent: 4496556 (1985-01-01), Orentreich
patent: 4518595 (1985-05-01), Coleman et al.
patent: 4542129 (1985-09-01), Orentreich
The Merck Index, 10th ed. (1983), #7606 Prasterone.

Affiliated with

Also associated with

Rating

Dehydroepiandrosterone therapy for ameleoration of prostate hype does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dehydroepiandrosterone therapy for ameleoration of prostate hype, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dehydroepiandrosterone therapy for ameleoration of prostate hype will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2152703